Gynium (Lactobacillus Gasseri Dsm 14869, Lactobacillus Rhamnosus Dsm 14870)

Gynium is indicated for conditions related to an imbalance of the vaginal ecosystem. It may be used to help restore a healthy microbial environment and reduce the risk of recurrent infections.

• Management of vaginal dysbiosis associated with altered lactobacilli levels.
• Adjunctive support after treatment of bacterial vaginosis to prevent recurrence.
• Maintenance of normal vaginal flora in women prone to microbial shifts.
• Complementary use during or after antibiotic therapy for genitourinary infections.
• General promotion of genitourinary health in women of reproductive age.

Side effects reported with vaginal probiotic preparations are generally mild and transient.

Common

• Mild vaginal irritation or itching.
• Slight increase in vaginal discharge that is clear or white.
• Temporary burning sensation during application.
• Minor spotting or spotting after insertion.
• Mild abdominal cramping.

Serious

• Persistent or worsening vaginal pain.
• Signs of allergic reaction such as swelling, rash, or hives.
• Fever or chills accompanied by vaginal symptoms.
• Unusual foul odor suggesting secondary infection.
• Severe pelvic pain requiring medical evaluation.

Before using Gynium, consider the following safety points. The product is intended for external vaginal use only and should not be introduced into the uterus or bloodstream.

• Do not use if you have a known hypersensitivity to any Lactobacillus species.
• Consult a healthcare professional if you are pregnant, planning pregnancy, or breastfeeding.
• Avoid use during active severe vaginal infections without prior medical assessment.
• Discontinue use and seek medical advice if symptoms persist beyond a few days.
• Store the product according to the label, protecting it from excessive heat and moisture.
• Keep out of reach of children; accidental ingestion should be reported to a poison control center.

Gynium may interact with other products applied to the vaginal area or systemic medications that affect the microbiome.

Avoid

• Simultaneous use of intravaginal antiseptics, douches, or spermicidal gels that could disrupt probiotic viability.
• Insertion of other vaginal tablets or suppositories within the same dosing interval.

Use with caution

• Antibiotic therapy, which may reduce probiotic colonization; timing of administration should be discussed with a clinician.
• Hormonal contraceptives or hormone replacement therapy, as hormonal changes can influence vaginal flora.
• Immunosuppressive medications, especially in patients with compromised immunity.
• Systemic probiotics taken orally, to avoid potential over‑colonization.
• Any intravaginal medical devices (e.g., diaphragms) that may alter the local environment.